Maxigen Biotech

Maxigen Biotech Inc. (hereinafter referred to as Maxigen) is engaged in the research and development of collagen. Maxigen's biomedical plant has obtained Taiwan GMP, international ISO13485, and South Korea KGMP certifications. It was also inspected on-site by the U.S. FDA in 2009 and 2015, with production quality meeting international standards. Maxigen's biomedical products are mainly applied in orthopedics, medical aesthetics, dentistry, general surgery, and ophthalmology. The company has obtained 56 product certifications globally, with sales reaching over 50 countries across Asia, Europe, Africa, and North America, as well as other emerging markets.